Drawing for ELYSIA

USPTO serial 99676676

ELYSIA

Status 641Office Action
Filing date
Mar 1, 2026
Status date
Jun 29, 2026
Registration date
Examiner
QUEEN, ESTHER FELICIA

Need help with ELYSIA?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: September 29, 2026

Office Action issues

The trademark examiner has refused your application due to a potential likelihood of confusion with an existing registration and noted a prior-filed pending application that could affect your status.

Owner

  • YM Family LLC

    Seattle, WA, US

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services; Business and management consulting for healthcare providers and related businesses; Pharmaceutical cost management services and drug utilization review services; Health care cost review; Vendor management services for healthcare facilities; Consulting services in the cost management of health care; Marketing research services; Business strategic planning services; Collection and analysis of healthcare quality data for business purposes; Providing information and analysis in the fields of economics and business; Economic forecasting analysis for business purposes; Consumer strategy business consulting in the fields of marketing, sales, operation, and product design particularly specializing in the use of analytic models for the understanding and predicting of consumer, business, and retail market trends and actions; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Analysis of market research data and statistics; Statistical evaluations of marketing data; Providing economic consultation in the field of healthcare and pharmaceuticals; Business data analysis services in the field of healthcare and pharmaceuticals; Public policy consultancy in the field of healthcare and pharmaceuticalsACTIVESep 23, 2023

Prosecution history

DateCodeEvent
Jun 29, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2026GNRTNON-FINAL ACTION E-MAILED
Jun 29, 2026CNRTNON-FINAL ACTION WRITTEN
Jun 29, 2026DOCKASSIGNED TO EXAMINER
Jun 28, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Mar 1, 2026NWAPNEW APPLICATION ENTERED

Related guidance